skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Optimization of Boron Neutron Capture Therapy for the Treatment of Undifferentiated Thyroid Cancer

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
;  [1];  [2];  [1]; ;  [2];  [3];  [1];  [4];  [1];  [1]
  1. Department of Radiobiology (Constituyentes Atomic Center), National Atomic Energy Commission of Argentina, Buenos Aires (Argentina)
  2. Nuclear Reactor RA-6 (Bariloche Atomic Center), National Atomic Energy Commission of Argentina, Buenos Aires (Argentina)
  3. Department of Chemistry (Constituyentes Atomic Center), National Atomic Energy Commission of Argentina, Buenos Aires (Argentina)
  4. Department of Pharmaceutical Chemistry, University of California, San Francisco, CA (United States)

Purpose: To analyze the possible increase in efficacy of boron neutron capture therapy (BNCT) for undifferentiated thyroid carcinoma (UTC) by using p-boronophenylalanine (BPA) plus 2,4-bis ({alpha},{beta}-dihydroxyethyl)-deutero-porphyrin IX (BOPP) and BPA plus nicotinamide (NA) as a radiosensitizer of the BNCT reaction. Methods and Materials: Nude mice were transplanted with a human UTC cell line (ARO), and after 15 days they were treated as follows: (1) control, (2) NCT (neutrons alone), (3) NCT plus NA (100 mg/kg body weight [bw]/day for 3 days), (4) BPA (350 mg/kg bw) + neutrons, (5) BPA + NA + neutrons, and (6) BPA + BOPP (60 mg/kg bw) + neutrons. The flux of the mixed (thermal + epithermal) neutron beam was 2.8 x 10{sup 8} n/cm{sup 2}/sec for 83.4 min. Results: Neutrons alone or with NA caused some tumor growth delay, whereas in the BPA, BPA + NA, and BPA + BOPP groups a 100% halt of tumor growth was observed in all mice at 26 days after irradiation. When the initial tumor volume was 50 mm{sup 3} or less, complete remission was found with BPA + NA (2 of 2 mice), BPA (1 of 4), and BPA + BOPP (7 of 7). After 90 days of complete regression, recurrence of the tumor was observed in BPA + NA (2 of 2) and BPA + BOPP (1 of 7). The determination of apoptosis in tumor samples by measurements of caspase-3 activity showed an increase in the BNCT (BPA + NA) group at 24 h (p < 0.05 vs. controls) and after the first week after irradiation in the three BNCT groups. Terminal transferase dUTP nick end labeling analysis confirmed these results. Conclusions: Although NA combined with BPA showed an increase of apoptosis at early times, only the group irradiated after the combined administration of BPA and BOPP showed a significantly improved therapeutic response.

OSTI ID:
21039616
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Vol. 69, Issue 4; Other Information: DOI: 10.1016/j.ijrobp.2007.04.061; PII: S0360-3016(07)00699-2; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0360-3016
Country of Publication:
United States
Language:
English

Similar Records

First Evaluation of the Biologic Effectiveness Factors of Boron Neutron Capture Therapy (BNCT) in a Human Colon Carcinoma Cell Line
Journal Article · Sat Jan 01 00:00:00 EST 2011 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:21039616

Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent
Journal Article · Sat Jan 01 00:00:00 EST 1994 · Radiation Research · OSTI ID:21039616

Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy
Journal Article · Mon Nov 01 00:00:00 EST 2004 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:21039616